Holen Sie sich die Stockscreener-App
3.26
1.81%
-0.06
Finanzdaten der Prelude Therapeutics Inc-Aktie (PRLD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
24.54%
5.704
|
4.58 | 5.64 | 6.50 | - |
| Operating Expenses |
12.80%
21.16
|
18.76 | 22.99 | 26.92 | 32.19 |
| Operating Income/Loss |
9.01%
-15.45
|
-14.18 | -17.35 | -20.42 | -32.19 |
| Net Income/Loss |
34.05%
-13.92
|
-10.38 | -16.46 | -19.73 | -31.23 |
| Basic Average Shares |
19.23%
98.39
|
82.52 | 0.9181 | 76.13 | 75.99 |
| Diluted Average Shares |
19.23%
98.39
|
82.52 | 0.9181 | 76.13 | 75.99 |
| Basic Earnings Per Share |
7.69%
-0.14
|
-0.13 | -0.20 | -0.26 | -0.41 |
| Diluted Earnings Per Share |
7.69%
-0.14
|
-0.13 | -0.20 | -0.26 | -0.41 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):